Related references
Note: Only part of the references are listed.The ameliorating effect of cannabinoid type 2 receptor activation on brain, lung, liver and heart damage in cecal ligation and puncture-induced sepsis model in rats
Murat Cakir et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice
Jadna B. Lopes et al.
PSYCHOPHARMACOLOGY (2020)
Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease
Shelly Tartakover Matalon et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice
Ewa Poleszak et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Cannabinoid type 2 receptor agonist JWH133 decreases blood pressure of spontaneously hypertensive rats through relieving inflammation in the rostral ventrolateral medulla of the brain
He-Kai Shi et al.
JOURNAL OF HYPERTENSION (2020)
JWH133 inhibits MPP+ -induced inflammatory response and iron influx in astrocytes
Yi Jia et al.
NEUROSCIENCE LETTERS (2020)
Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice
Ewa Poleszak et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy
Bhavna Gupta et al.
FRONTIERS IN PEDIATRICS (2020)
Exogenous activation of cannabinoid-2 receptor modulates TLR4/MMP9 expression in a spinal cord ischemia reperfusion rat model
Na Jing et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear
Devon Ivy et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice
Ewa Poleszak et al.
PHARMACOLOGICAL REPORTS (2020)
Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain
David Cabanero et al.
ELIFE (2020)
Activation of cannabinoid receptor 2 protects rat hippocampal neurons against Aβ-induced neuronal toxicity
Jingfu Zhao et al.
NEUROSCIENCE LETTERS (2020)
Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine
Pedro H. Gobira et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Mechanisms of cannabinoid CB2 receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area
Zegang Ma et al.
EBIOMEDICINE (2019)
Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
Wen S. Sheng et al.
PAIN RESEARCH & MANAGEMENT (2019)
Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system
Ana Martin-Sanchez et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice
Lindsey Shapiro et al.
EPILEPSIA (2019)
Selective Activation of Cannabinoid Receptor 2 Attenuates Myocardial Infarction via Suppressing NLRP3 Inflammasome
Wen Yu et al.
INFLAMMATION (2019)
Cannabinoid Receptor 2 Agonist Prevents Local and Systemic Inflammatory Bone Destruction in Rheumatoid Arthritis
Mo Zhu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Cannabinoid type 2 receptor agonist JWH-133, attenuates Okadaic acid induced spatial memory impairment and neurodegeneration in rats
Murat Cakir et al.
LIFE SCIENCES (2019)
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks
Thercia G. Viana et al.
NEUROPHARMACOLOGY (2019)
Liver X Receptor α-Induced Cannabinoid Receptor 2 Inhibits Ubiquitin-Specific Peptidase 4 Through miR-27b, Protecting Hepatocytes From TGF-β
Hong Min Wu et al.
HEPATOLOGY COMMUNICATIONS (2019)
Cannabinoids for epilepsy: What do we know and where do we go?
Martin J. Brodie et al.
EPILEPSIA (2018)
Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway
Lin Wang et al.
MOLECULAR NEUROBIOLOGY (2018)
A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats
Lin Li et al.
BRAIN RESEARCH (2018)
New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism
Elizabeth A. Vecchio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
An overview of the cannabinoid type 2 receptor system and its therapeutic potential
Bihua Bie et al.
CURRENT OPINION IN ANESTHESIOLOGY (2018)
The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-beta Neurotoxicity in CB2R(-/-) Mice
Lin Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects
Aitziber Mendiguren et al.
LIFE SCIENCES (2018)
SozRank: A new approach for localizing the epileptic seizure onset zone
Yonathan Murin et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Emerging strategies targeting CB2 cannabinoid receptor: Biased agonism and allosterism
Paula Morales et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol
Francisco Navarrete et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure
Patricia Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2018)
The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus
Qiong Wu et al.
EPILEPSY RESEARCH (2018)
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
Hai-Ying Zhang et al.
ADDICTION BIOLOGY (2017)
Cannabinoids in treatment-resistant epilepsy: A review
Brooke K. O'Connell et al.
EPILEPSY & BEHAVIOR (2017)
PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats
Geraldine Pottier et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity
Lingling Sun et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain
Matthew B. Yuill et al.
MOLECULAR PAIN (2017)
A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix Hemorrhage in the preterm via CX3CR1+ microglia
Jun Tang et al.
NEUROPHARMACOLOGY (2017)
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice
Marta Kruk-Slomka et al.
NEUROTOXICITY RESEARCH (2017)
Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain
Glria Salort et al.
PSYCHOPHARMACOLOGY (2017)
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Marjolein Soethoudt et al.
NATURE COMMUNICATIONS (2017)
Inflammatory Regulations by Driving Microglial M2 Polarization: Neuroprotective Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage
Li Lin et al.
FRONTIERS IN IMMUNOLOGY (2017)
Anxiety disorders
Michelle G. Craske et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Brain cannabinoid receptor 2: expression, function and modulation
De-Jie Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage
Qiang Tan et al.
BRAIN RESEARCH (2017)
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2
Jun Tang et al.
MOLECULAR NEUROBIOLOGY (2016)
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB2 Receptors
Maria S. Aymerich et al.
MOLECULAR NEUROBIOLOGY (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model
Yihao Tao et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
Shanshan Wang et al.
BRAIN RESEARCH BULLETIN (2016)
Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists
Mojgan Aghazadeh Tabrizi et al.
CHEMICAL REVIEWS (2016)
JWH-133, a Selective Cannabinoid CB2 Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells
Jakub Wojcieszak et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel et al.
NEURON (2016)
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease
Attila Kofalvi et al.
NEUROPHARMACOLOGY (2016)
Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile
M. Gomez-Canas et al.
PHARMACOLOGICAL RESEARCH (2016)
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti et al.
PROGRESS IN LIPID RESEARCH (2016)
Treatment-resistant panic disorder: clinical significance, concept and management
Mu-Hong Chen et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
Marta Kruk-Slomka et al.
NEURAL PLASTICITY (2016)
Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
Jorge Navarro-Dorado et al.
FRONTIERS IN NEUROSCIENCE (2016)
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease
Young C. Chung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice
M. Alipour et al.
DRUG RESEARCH (2016)
Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway
Amey Dhopeshwarkar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus
Lei Zheng et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors
Matthew S. Powers et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)
Emerging Concepts in Alzheimer's Disease
Harry V. Vinters
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
Marta Kruk-Slomka et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model
Yihao Tao et al.
BRAIN RESEARCH (2015)
Endocannabinoid signalling in innate and adaptive immunity
Valerio Chiurchiu et al.
IMMUNOLOGY (2015)
Evaluation of the effects of Eserine and JWH-133 on brain dysfunction associated with experimental endotoxemia
Maha Gamal et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission
Jimok Kim et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro
Jun Tang et al.
NEUROPHARMACOLOGY (2015)
NEURONAL EXPRESSION OF CB2 CANNABINOID RECEPTOR mRNAs IN THE MOUSE HIPPOCAMPUS
Y. Li et al.
NEUROSCIENCE (2015)
Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
Weisi Fu et al.
NEUROSCIENCE LETTERS (2015)
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Javier Fernandez-Ruiz et al.
NEUROTHERAPEUTICS (2015)
Role of CB2 receptors in social and aggressive behavior in male mice
Marta Rodriguez-Arias et al.
PSYCHOPHARMACOLOGY (2015)
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons
Alvaro Llorente-Berzal et al.
PSYCHOPHARMACOLOGY (2015)
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain
Patricia Rivera et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats
Lin Li et al.
TRANSLATIONAL STROKE RESEARCH (2015)
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease
Amandine E. Bonnet et al.
AGING AND DISEASE (2015)
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats
Hai-Ying Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Regulatory role of the cannabinoid CB2 receptor in stress- induced neuroinflammation in mice
S. Zoppi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
A. -L. Klauke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury
Peter S. Amenta et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats
Mutsumi Fujii et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Every Newborn: progress, priorities, and potential beyond survival
Joy E. Lawn et al.
LANCET (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
In-Young Choi et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors
J. M. Franklin et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists
Servio H. Ramirez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors
Maria S. Garcia-Gutierrez et al.
NEUROPHARMACOLOGY (2013)
Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing, and Physical Effects of Nicotine
Francisco Navarrete et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy
Gema Vera et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
Rai Khalid Farooq et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Effects of Se-phenyl thiazolidine-4-carboselenoate on mechanical and thermal hyperalgesia in brachial plexus avulsion in mice: Mediation by cannabinoid CB1 and CB2 receptors
Lucian Del Fabbro et al.
BRAIN RESEARCH (2012)
Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice
Francisco Navarrete et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
Maria S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Bela Horvath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
Ana Maria Martin-Moreno et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier
Michelle A. Erickson et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
Servio H. Ramirez et al.
JOURNAL OF NEUROSCIENCE (2012)
Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors
Auxiliadora Aracil-Fernandez et al.
NEUROPSYCHOPHARMACOLOGY (2012)
SPINAL CANNABINOID CB2 RECEPTORS AS A TARGET FOR NEUROPATHIC PAIN: AN INVESTIGATION USING CHRONIC CONSTRICTION INJURY
P. W. Brownjohn et al.
NEUROSCIENCE (2012)
REDUCED INFARCT SIZE AND ACCUMULATION OF MICROGLIA IN RATS TREATED WITH WIN 55,212-2 AFTER NEONATAL STROKE
D. Fernandez-Lopez et al.
NEUROSCIENCE (2012)
CANNABINOID RECEPTOR SUBTYPES 1 AND 2 MEDIATE LONG-LASTING NEUROPROTECTION AND IMPROVE MOTOR BEHAVIOR DEFICITS AFTER TRANSIENT FOCAL CEREBRAL ISCHEMIA
W. Schmidt et al.
NEUROSCIENCE (2012)
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
Femke S. den Boon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
Juan G. Zarruk et al.
STROKE (2012)
Brain Cell Reservoirs of Latent Virus in Presymptomatic HIV-Infected Individuals
Katherine A. Thompson et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
C. Garcia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice
Verdad Curto-Reyes et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Immunomodulatory Properties of Kappa Opioids and Synthetic Cannabinoids in HIV-1 Neuropathogenesis
Shuxian Hu et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Cannabinoids Inhibit Migration of Microglial-like Cells to the HIV Protein Tat
Daniel Fraga et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Cannabinoid Neuroimmune Modulation of SIV Disease
Patricia E. Molina et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
Jose L. Lanciego et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
Grand challenges in global mental health
Pamela Y. Collins et al.
NATURE (2011)
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng-Xiong Xi et al.
NATURE NEUROSCIENCE (2011)
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro et al.
NEUROPSYCHOPHARMACOLOGY (2011)
New insights into the pathophysiology of postoperative cognitive dysfunction
L. Krenk et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2010)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
M. S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment
Sasidhar Murikinati et al.
FASEB JOURNAL (2010)
Brain Microglial Cytokines in Neurogenic Hypertension
Peng Shi et al.
HYPERTENSION (2010)
Typical Cerebral Metabolic Patterns in Neurodegenerative Brain Diseases
Laura K. Teune et al.
MOVEMENT DISORDERS (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Mechanisms of Neurodegeneration and Regeneration in Alcoholism
Fulton T. Crews et al.
ALCOHOL AND ALCOHOLISM (2009)
Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain
C. Z. Zhu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis
Ryan J. McLaughlin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
Q. -R. Liu et al.
GENES BRAIN AND BEHAVIOR (2009)
Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
Maria Teresa Viscomi et al.
JOURNAL OF NEUROSCIENCE (2009)
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
Zahida Qamri et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Self-modulation of neocortical pyramidal neurons by endocannabinoids
Silvia Marinelli et al.
NATURE NEUROSCIENCE (2009)
Characterizing Cannabinoid CB2 Receptor Ligands Using DiscoveRx PathHunter (TM) beta-Arrestin Assay
Debra Mcguinness et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Addiction and the brain antireward system
George F. Koob et al.
ANNUAL REVIEW OF PSYCHOLOGY (2008)
The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms
Carl Potenzieri et al.
BRAIN RESEARCH (2008)
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI
C-L Chin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
M. Naguib et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats
M. D. Jhaveri et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation
Sachin Patel et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain
Wataru Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney
Abdolamir Feizi et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2008)
Cannabinoid-mediated neuroprotection, not immuno suppression, may be more relevant to multiple sclerosis
J. Ludovic Croxford et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Role of CB2 receptors in neuroprotective effects of cannabinoids
Javier Fernandez-Ruiz et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons
Uma Anand et al.
PAIN (2008)
Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
Emmanuel S. Onaivi et al.
PLOS ONE (2008)
Novel cannabinoid receptors
A. J. Brown
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice
Mohammad R. Jafari et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Neurodevelopmental outcome in survivors of periventricular hemorrhagic infarction
Haim Bassan et al.
PEDIATRICS (2007)
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Javier Fernandez-Ruiz et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Molecular targets in cerebral ischemia for developing novel therapeutics
Suresh L. Mehta et al.
BRAIN RESEARCH REVIEWS (2007)
Diagnosis and treatment of Parkinson disease: molecules to medicine
Joseph M. Savitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
Y Yiangou et al.
BMC NEUROLOGY (2006)
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms
M Beltramo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat
SJR Elmes et al.
PAIN (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats
DR Sagar et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
Prevention of Alzheimer's disease pathology by cannabinoids:: Neuroprotection mediated by blockade of microglial activation
BG Ramírez et al.
JOURNAL OF NEUROSCIENCE (2005)
Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies
PT Hansson et al.
PAIN (2005)
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism
EJ Carrier et al.
MOLECULAR PHARMACOLOGY (2004)
Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis
S Patel et al.
ENDOCRINOLOGY (2004)
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain
SJR Elmes et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Temporally specific burst in cell proliferation increases hippocampal neurogenesis in protracted abstinence from alcohol
K Nixon et al.
JOURNAL OF NEUROSCIENCE (2004)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors
A Quartilho et al.
ANESTHESIOLOGY (2003)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain:: Pain inhibition by receptors not present in the CNS
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
CB2 cannabinoid receptor agonists:: pain relief without psychoactive effects?
TP Malan et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Axonal degeneration and progressive neurologic disability in multiple sclerosis
C Bjartmar et al.
NEUROTOXICITY RESEARCH (2003)
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence
A Castañé et al.
NEUROPHARMACOLOGY (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Resorcinol derivatives:: A novel template for the development of cannabinoid CB1/CB2 and CB2-selective agonists
JL Wiley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ);: Retards Aβ aggregation, deposition, fibril formation, and inhibits cytotoxicity.
JG Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cannabinoids control spasticity and tremor in a multiple sclerosis model
D Baker et al.
NATURE (2000)
Share Paper
